Prelude to Thinking About $1.5 Billion: Fresh Info on California's Neuro Disease Portfolio
The California stem cell agency today posted additional information dealing with its potential strategy to spend $1.5 billion on neuro diseases ranging from Parkinson’s to depression.
A meeting is scheduled for next Tuesday to discuss a plan. The new postings include a review of what the agency has done over the last 18 years, which is considerable, alo…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.